Genetic Technologies Limited (GENE)

Genetic Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	13	18	59	11	10
Market Cap Growth	-98.37%	-28.38%	-69.49%	424.15%	16.56%	-40.40%
Enterprise Value	4	8	10	43	2	8
PE Ratio	-	-1.58	-3.60	-11.00	-2.57	-2.12
PS Ratio	1.05	2.13	3.78	645.62	1641.24	534.58
PB Ratio	1.88	1.66	1.57	3.62	1.16	7.68
P/FCF Ratio	-0.09	-1.90	-4.49	-11.05	-2.83	-2.22
P/OCF Ratio	-0.09	-1.91	-4.54	-12.36	-2.83	-2.24
EV/Sales Ratio	0.66	1.29	2.15	473.93	249.07	450.80
EV/EBITDA Ratio	-	-0.94	-2.05	-8.09	-0.39	-1.79
EV/EBIT Ratio	0.21	-0.94	-2.05	-8.09	-0.39	-1.79
EV/FCF Ratio	0.35	-1.15	-2.56	-8.11	-0.43	-1.87
Debt / Equity Ratio	0.08	0.05	0.04	0.01	0.03	-
Debt / EBITDA Ratio	-	-0.04	-0.09	-0.03	-0.08	-
Debt / FCF Ratio	-0.05	-0.05	-0.11	-0.03	-0.08	-
Quick Ratio	1.42	2.95	3.71	15.64	10.74	1.98
Current Ratio	1.67	3.17	3.86	15.82	10.87	2.14
Asset Turnover	0.70	0.49	0.31	0.01	0.00	0.01
Interest Coverage	-480.22	-402.50	-469.79	-432.20	-86.33	-319.78
Return on Equity (ROE)	-160.90%	-85.20%	-37.60%	-39.80%	-79.90%	-198.20%
Return on Assets (ROA)	-105.50%	-65.90%	-32.60%	-36.70%	-66.60%	-136.30%
Return on Capital (ROIC)	-285.91%	-119.16%	-58.35%	-39.95%	-50.87%	-396.22%
Earnings Yield	-143.54%	-63.38%	-27.74%	-9.09%	-38.88%	-47.24%
FCF Yield	-84.47%	-52.54%	-22.26%	-9.05%	-35.29%	-45.02%
Buyback Yield / Dilution	-28.00%	-9.95%	-7.91%	-105.63%	-57.66%	-8.22%
Total Shareholder Return	-28.00%	-9.95%	-7.91%	-105.63%	-57.66%	-8.22%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).